Management of Incapacitating Nerve Pain

Pharmacological Interventions

• First-line neuropathic pain medications, such as gabapentin or pregabalin, combined with SNRIs or TCAs, are recommended, with a treatment approach that includes starting gabapentin at 600mg on day 1, then titrating every 3 days to 1800mg daily, and pregabalin as an alternative with more predictable pharmacokinetics, starting at 75mg at bedtime with gradual weekly increase to 150-300mg daily, as recommended by the American College of Physicians 1
• Capsaicin may be considered for patients with localized pain areas, according to the National Comprehensive Cancer Network 2
• Duloxetine is considered as the next therapeutic option for neuropathic pain management, with a starting dose of 30 mg daily for one week, then increased to 60 mg daily if tolerated, as recommended by the Clinical Infectious Diseases guideline and the American Diabetes Association 3, 4, 5
• Amitriptyline or imipramine have a balanced inhibition of norepinephrine and serotonin reuptake, with a starting dose of 10mg at bedtime, and have a number needed to treat (NNT) of 1.5-3.5, as suggested by the Clinical Infectious Diseases guideline 6, 3, 5, 7
• Tramadol is a weak μ-opioid agonist plus norepinephrine and serotonin reuptake inhibitor, with a starting dose of 50mg once or twice daily, and is best used for short-term relief when immediate pain control is needed, as recommended by the American Heart Association 8, 1, 9
• Opioids, such as morphine, are effective for short-term pain relief but carry significant risks, including addiction, dependency, depression, and death, as warned by the American Heart Association 9

Interventional Procedures

• Spinal cord stimulation may be considered for long-term refractory cases, as suggested by the National Comprehensive Cancer Network, with evidence supporting its use in patients who have failed other treatments 10, 2
• Intercostal nerve blocks may be used for refractory pain, as suggested by the National Comprehensive Cancer Network 2
• Local corticosteroid injections at the site of nerve compression, such as the inguinal ligament, may be considered for patients with persistent symptoms despite conservative management, as recommended by the American Society of Regional Anesthesia and Pain Medicine 1
• Surgical options, such as neurolysis or neurectomy, may be considered for patients with refractory symptoms despite conservative management and injections, as suggested by the American Academy of Orthopaedic Surgeons 1

Non-Pharmacological Interventions

• Exercise therapy focusing on strengthening and flexibility, weight loss for overweight patients, avoidance of tight clothing or other mechanical irritants, and cognitive behavioral therapy for pain management can be beneficial for patients with allodynia, as suggested by the Clinical Infectious Diseases guideline 3
• Weight-bearing exercises and physical rehabilitation are recommended, as suggested by the National Comprehensive Cancer Network 2
• Cognitive behavioral therapy is strongly recommended for chronic pain management, as it helps promote patient acceptance of responsibility for change and addresses maladaptive behaviors and develops adaptive coping strategies, as recommended by the Clinical Infectious Diseases guideline 3
• Exercise is strongly recommended for chronic pain management, focusing on strengthening, flexibility, and proper body mechanics, as suggested by the Clinical Infectious Diseases guideline 3, 11, 5
• Yoga is recommended for neck/back pain, headache, and musculoskeletal pain, hypnosis is recommended for neuropathic pain, and acupuncture may be considered with a weak recommendation and moderate evidence, as suggested by the Clinical Infectious Diseases guideline 3

Evaluation and Monitoring

• A comprehensive neuropathy evaluation should include laboratory tests such as HbA1c, Vitamin B12 levels, Thyroid stimulating hormone (TSH), Vitamin B6 levels, Folate levels, Serum protein electrophoresis and immunofixation, and Creatine phosphokinase (CPK), as recommended by the Clinical Infectious Diseases guideline 12
• Regular reassessment of headache control and medication effectiveness is necessary, and monitor for achievement of functional goals, document pain intensity, quality of life, and adverse events, and adjust treatment plan as needed, as suggested by the Clinical Infectious Diseases guidelines 3
• Referral to neurology should be considered if symptoms persist or worsen despite intervention, as recommended by the Clinical Infectious Diseases guideline and the American College of Physicians 12, 3

Lifestyle Modifications

• Weight loss is recommended for overweight patients with meralgia paresthetica to reduce symptoms, as recommended by the American Heart Association 1
• Avoidance of tight clothing, belts, or corsets, and activity modification to reduce compression of the nerve is recommended, as suggested by the American Academy of Physical Medicine and Rehabilitation 1